SCHEMBL4133274

SCHEMBL4133274

O=C1N=C(Nc2ccc(C(Br)C(=O)O)c(F)c2)SC1=Cc1ccc(Cl)c([N+](=O)[O-])c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 10/20 0.41
KMT2A Q03164 10/20 0.41
MAPT P10636 8/20 0.41
ALDH1A1 P00352 5/20 0.41
POLB P06746 3/20 0.41
PKM P14618 1/20 0.41
GSK3B P49841 2/20 0.39
CISD1 Q9NZ45 1/20 0.37
VCAM1 P19320 1/20 0.34
LMNA P02545 1/20 0.34
GAA P10253 1/20 0.34
HTT P42858 1/20 0.34
ALOX5 P09917 2/20 0.34
PSMD14 O00487 2/20 0.33
HSP90AA1 P07900 2/20 0.33
MMP2 P08253 2/20 0.33
NPSR1 Q6W5P4 2/20 0.33
MAPK1 P28482 1/20 0.33
CRHBP P24387 1/20 0.33
CRHR2 Q13324 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4133272 1.00 MEN1 (0.41) MEN1KMT2AMAPTALDH1A1POLB
SCHEMBL4634491 0.77 P2RX3 (0.33) MAPTALDH1A1POLBMMP2MAPK1
SCHEMBL4128820 0.77 KMT2A (0.47) MEN1KMT2AMAPTALDH1A1POLB
SCHEMBL4128816 0.77 KMT2A (0.47) MEN1KMT2AMAPTALDH1A1POLB
SCHEMBL4137074 0.77 ALOX5 (0.36) MAPTPOLBCISD1ALOX5
SCHEMBL4143591 0.76 MAOA (0.43) CISD1ALOX5
SCHEMBL4143594 0.76 MAOA (0.43) CISD1ALOX5
SCHEMBL4140153 0.73 HDAC1 (0.32) MEN1KMT2AMAPTCISD1ALOX5
SCHEMBL4140156 0.73 HDAC1 (0.32) MEN1KMT2AMAPTCISD1ALOX5
SCHEMBL4134174 0.72 AKR1C3 (0.36) MEN1KMT2AMAPTPOLBLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090088432-A1 Thiazolinones and Oxazolinones and their Use as Ptp1b Inhibitors TORRENT PHARMACEUTICALS LIMITED (IN) 2009-04-02 US claimed
US-20090088432-A1 Thiazolinones and Oxazolinones and their Use as Ptp1b Inhibitors TORRENT PHARMACEUTICALS LIMITED (IN) 2009-04-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090088432-A1 Thiazolinones and Oxazolinones and their Use as Ptp1b Inhibitors PTPRF, PTPA, PTPRJ MEN1 4075/4885KMT2A 2895/4885MAPT 3532/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.